Related Experiment Video
Updated: Jun 13, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
An update on the relationships between rheumatoid arthritis and atherosclerosis
Zeynep Ozbalkan1, Cumali Efe, Mustafa Cesur
1Department of Rheumatology, Ankara Numune Hospital, Turkey. z.aslar@hotmail.com
Insights
Rheumatoid arthritis (RA) patients face higher cardiovascular risks due to chronic inflammation driving atherosclerosis. This review explores the link between RA and the inflammatory processes underlying cardiovascular disease.
Area of Science:
- Rheumatology
- Cardiovascular Medicine
- Immunology
Background:
- Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease.
- Cardiovascular events are the leading cause of death in RA patients.
- Chronic inflammation in RA contributes significantly to atherosclerosis development.
Purpose of the Study:
- To analyze the complex relationship between rheumatoid arthritis and atherosclerosis.
- To highlight the role of chronic systemic inflammation in cardiovascular disease progression in RA patients.
Main Methods:
- Literature review of studies investigating rheumatoid arthritis and atherosclerosis.
- Analysis of the inflammatory pathways involved in both conditions.
Main Results:
- Atherosclerosis is an active inflammatory process, not merely lipid accumulation.
- Shared inflammatory cells like macrophages, monocytes, and T cells are implicated in both RA and atherosclerosis.
- Chronic systemic inflammation is a key driver of endothelial dysfunction, plaque rupture, and thrombosis in RA.
Conclusions:
- There is a strong link between rheumatoid arthritis and atherosclerosis, driven by shared inflammatory mechanisms.
- Understanding these connections is crucial for managing cardiovascular risk in RA patients.
- Targeting inflammation may be key to preventing cardiovascular events in rheumatoid arthritis.
Abstract:
Rheumatoid arthritis is a chronic inflammatory disease. Cardiovascular events are the most important cause of mortality and morbidity in patients with rheumatoid arthritis. Beyond the traditional cardiovascular risk factors, chronic systemic inflammation has been shown to be a crucial factor in atherosclerosis development and progression from endothelial dysfunction to plaque rupture and thrombosis. Many studies have shown that atherosclerosis is not a passive event like accumulation of lipids in the vessel walls; by contrast, it represents an active inflammation of the vessels. Inflammatory cells such as macrophages, monocytes and T cells play important roles in the development of both rheumatoid arthritis and atherosclerosis. In this article we analyse the relationships between rheumatoid arthritis and atherosclerosis.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
